2 research outputs found
Modelling drug release from polymer-free coronary stents with microporous surfaces
Traditional coronary drug-eluting stents (DES) are made from metal and are coated with a permanent polymer
film containing an anti-proliferative drug. Subsequent to stent deployment in a diseased coronary artery, the
drug releases into the artery wall and helps prevent restenosis by inhibiting the proliferation of smooth muscle
cells. Although this technology has proven to be remarkably successful, there are ongoing concerns that the
presence of a polymer in the artery can lead to deleterious medical complications, such as late stent thrombosis.
Polymer-free DES may help overcome such shortcomings. However, the absence of a rate-controlling polymer
layer makes optimisation of the drug release profile a particular challenge. The use of microporous stent surfaces
to modulate the drug release rate is an approach that has recently shown particularly promising clinical results.
In this study, we develop a mathematical model to describe drug release from such stents. In particular, we
develop a mathematical model to describe drug release from microporous surfaces. The model predicts a twostage
release profile, with a relatively rapid initial release of most of the drug, followed by a slower release of the
remaining drug. In the model, the slow release phase is accounted for by an adsorption/desorption mechanism
close to the stent surface. The theoretical predictions are compared with experimental release data obtained in
our laboratory, and good agreement is found. The valuable insights provided by our model will serve as a useful
guide for designing the enhanced polymer-free stents of the future
Additional file 6: Figure S6. of Insulin and IGF1 signalling pathways in human astrocytes in vitro and in vivo; characterisation, subcellular localisation and modulation of the receptors
Reduced IGF1R but not downstream signalling in human astrocytes derived from temporal lobe resections using MAB391. Human astrocytes treated with MAB391 for 24 h. A) Immunoblots for IGF1R, pAkt, total Akt, pP44/42 MAPK and total p44/42 MAPK. α-tubulin was used as a loading control for blots. Molecular weight markers are indicated (kDa). (B) Bar charts showing quantification of blots, pAkt was normalised to Akt/tubulin. students unpaired t-test, **** p < 0.0001. (TIFF 1949 kb